Relmada Therapeutics, Inc.

8-K Regulation FD disclosure Jul 28, 2026 8-K Amended charter or bylaws; Shareholder vote results May 28, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Mar 9, 2026 8-K Director or officer change Dec 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 5, 2025 8-K Regulation FD disclosure; Other events Nov 4, 2025 8-K Regulation FD disclosure Sep 17, 2025 8-K Other events Sep 16, 2025 8-K Regulation FD disclosure Sep 10, 2025 8-K Regulation FD disclosure Sep 2, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Delisting notice or listing-rule failure Jul 23, 2025 8-K Terminated a material agreement Jul 10, 2025 8-K Regulation FD disclosure Jun 18, 2025 8-K Shareholder vote results May 27, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Changed accountants May 12, 2025 8-K Regulation FD disclosure; Other events Apr 28, 2025 8-K Results of operations (earnings release) Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 26, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Feb 6, 2025 8-K Delisting notice or listing-rule failure Jan 27, 2025 8-K Director or officer change Jan 6, 2025 8-K Regulation FD disclosure Dec 9, 2024 8-K Regulation FD disclosure Dec 4, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Shareholder vote results May 30, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) Mar 19, 2024 10-K Fiscal year ended 2023-12-31 Mar 19, 2024 8-K Director or officer change Jan 11, 2024